Today: 7 February 2026
Subscribe
Browse Category

Financial News News 13 December 2025 - 14 December 2025

BHP Group Ltd (BHP) Stock: This Week’s Key News, Price Drivers, and the Week-Ahead Outlook (Updated Dec. 14, 2025)

BHP Group Ltd (BHP) Stock: This Week’s Key News, Price Drivers, and the Week-Ahead Outlook (Updated Dec. 14, 2025)

Updated Sunday, December 14, 2025 (markets last closed Friday, December 12). BHP Group Ltd (ASX: BHP; LSE: BHP; NYSE: BHP) heads into the new trading week with investors weighing a familiar tug‑of‑war: iron ore stability versus “2026 supply” anxiety, copper’s powerful rally, and a fresh set of company headlines that touch both capital allocation and long-dated growth. On the Australian Securities Exchange, BHP closed at A$45.59 on Friday (Dec. 12)—up about 1.67% from the prior Friday close (Dec. 5), after notching an intraday high of A$45.98 during the week. Investing.comIn the U.S., BHP’s American Depositary Shares (ADS)—each representing two ordinary
14 December 2025
·······
Milestone Pharmaceuticals (MIST) Stock Update: FDA Approves CARDAMYST (Etripamil) — This Week’s Volatility, Analyst Forecasts, and What to Watch Next (Updated Dec. 12, 2025)

Milestone Pharmaceuticals (MIST) Stock Update: FDA Approves CARDAMYST (Etripamil) — This Week’s Volatility, Analyst Forecasts, and What to Watch Next (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025 (U.S. market close) Milestone Pharmaceuticals Inc. (NASDAQ: MIST) closed out the week in the spotlight after the company announced U.S. FDA approval of CARDAMYST™ (etripamil)—positioning Milestone to transition from a development-stage biotech to a commercial-stage cardiovascular company. GlobeNewswire+1 The stock action was anything but calm. MIST closed at $2.41 on Dec. 12, down 18.31%, after swinging through a wide intraday range and printing exceptionally heavy volume. After-hours trading showed a modest rebound. StockAnalysis Below is a detailed breakdown of the latest Milestone Pharmaceuticals news, this week’s trading story, forecasts and analyst targets, and the week-ahead
14 December 2025
·····
MercadoLibre Stock (NASDAQ: MELI) Weekly Update and Week-Ahead Outlook: Humanoid Robots Deal, $750M Notes, and Key Levels to Watch (Updated Dec. 12, 2025)

MercadoLibre Stock (NASDAQ: MELI) Weekly Update and Week-Ahead Outlook: Humanoid Robots Deal, $750M Notes, and Key Levels to Watch (Updated Dec. 12, 2025)

Updated: December 12, 2025 (U.S. market close)Meta description: MercadoLibre (MELI) ended the week near $2,016 after a volatile stretch that included a 5% midweek drop, a new humanoid-robot warehouse pilot, and a $750 million bond deal. Here’s what moved the stock this week and what investors are watching next week. MercadoLibre, Inc. (NASDAQ: MELI) closed Friday, Dec. 12, 2025 at $2,015.89, finishing a choppy week that featured a sharp selloff on Wednesday and a rebound attempt into the close. StockAnalysis The headline catalyst in the final days of the week wasn’t earnings—it was automation and capital markets. MercadoLibre announced a
14 December 2025
···
DoorDash Stock Forecast (DASH): News, Catalysts, and Week-Ahead Outlook After Friday’s $227.49 Close (Updated Dec. 12, 2025)

DoorDash Stock Forecast (DASH): News, Catalysts, and Week-Ahead Outlook After Friday’s $227.49 Close (Updated Dec. 12, 2025)

Updated: December 12, 2025 — DoorDash, Inc. (NASDAQ: DASH) ended Friday at $227.49, up 1.32% on the day, with a market value of roughly $99.6 billion. FinanceCharts+1 It was a volatile week for DoorDash stock: shares slid hard midweek as investors repriced the competitive outlook in online grocery and “instant” delivery, then stabilized as attention turned back to DoorDash’s scale, expansion strategy, and a fresh round of analyst updates. Investing.com+2Barron’s+2 Below is a comprehensive, publication-ready look at what moved DoorDash stock this week, the latest DoorDash news, and the key catalysts for the week ahead (Dec. 15–19). DoorDash stock price
13 December 2025
···
McKesson Stock Forecast: MCK Rebounds to $813.80 After Barclays’ Overweight Call — What to Watch Next Week (Updated Dec. 12, 2025)

McKesson Stock Forecast: MCK Rebounds to $813.80 After Barclays’ Overweight Call — What to Watch Next Week (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025 (U.S. market close) McKesson Corporation (NYSE: MCK) ended the week on a steadier footing after an early-week dip, closing Friday at $813.80. The stock is still down roughly 9% from its late-November 52‑week high ($895.58 on Nov. 26), but it remains one of healthcare’s stronger large-cap performers in 2025 as investors continue to reward its specialty-drug and oncology momentum, capital returns, and portfolio reshaping narrative. MarketWatch+1 Below is a detailed recap of what moved McKesson stock this week, the latest company and analyst developments, and the key catalysts traders are watching in the week ahead.
13 December 2025
·····
ADP Stock (NASDAQ: ADP) Update: What Drove Automatic Data Processing Shares This Week — and What to Watch Next Week (Updated Dec. 12, 2025)

ADP Stock (NASDAQ: ADP) Update: What Drove Automatic Data Processing Shares This Week — and What to Watch Next Week (Updated Dec. 12, 2025)

Automatic Data Processing, Inc. (ADP) stock finished the week on a stronger note even as broader markets pulled back. Shares closed Friday, Dec. 12, 2025 at $266.10, up 1.18% on the day and marking a third consecutive session of gains. MarketWatch Still, ADP remains well below its 52-week high near $329.93 (June 6), keeping the stock’s pullback narrative in focus heading into a data-heavy week for U.S. markets. MarketWatch Below is a full, updated look at ADP stock this week, the most important ADP headlines from the last several days, Wall Street forecasts, and the week-ahead catalysts that could move
13 December 2025
····
HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

Updated: December 12, 2025 (U.S. market close)HCA Healthcare, Inc. (NYSE: HCA) closed Friday at $484.77, finishing the week essentially flat—but not quiet. A sharp midweek drop and quick rebound put policy risk, reimbursement headlines, and year-end positioning back in the spotlight for America’s largest for-profit hospital operator. StockAnalysis+2MarketWatch+2 Below is what moved HCA stock this week, the most important HCA Healthcare news from the past several days, what analysts are forecasting now, and the key catalysts to watch in the week ahead. HCA stock this week: flat finish, big intrawEEK volatility HCA ended Friday (Dec. 12) at $484.77, up 0.50%
13 December 2025
·····
Lockheed Martin (LMT) Stock: This Week’s Rally, Fresh F-35 Headlines, and the Week-Ahead Outlook (Updated 12.12.2025)

Lockheed Martin (LMT) Stock: This Week’s Rally, Fresh F-35 Headlines, and the Week-Ahead Outlook (Updated 12.12.2025)

Lockheed Martin Corporation (NYSE: LMT) wrapped up the week with a strong move higher, closing at $480.25 on Friday, December 12, 2025, extending a nine-session winning streak even as broader U.S. equities finished the day lower. MarketWatch+1 For investors tracking LMT stock into next week, the story is a mix of momentum, contract-driven visibility, and headline risk—especially around the F-35 program after Switzerland said it will trim its planned purchase to stay within budget. Reuters Below is a detailed, Google News/Discover-ready roundup of what moved Lockheed Martin stock this week, the most important news from the last several days, updated
13 December 2025
·····
Starbucks Stock Forecast: SBUX News, This Week’s Price Action, and the Week Ahead Updated Dec. 12, 2025

Starbucks Stock Forecast: SBUX News, This Week’s Price Action, and the Week Ahead Updated Dec. 12, 2025

Updated: Friday, December 12, 2025Ticker: Starbucks Corporation (NASDAQ: SBUX) Starbucks stock ended the week on a steadier note after a choppy stretch that included a sharp early-week dip and a rebound into Friday’s close. Heading into next week, investors are weighing three near-term forces: labor headlines (as the workers’ strike expands), operational initiatives tied to CEO Brian Niccol’s “Back to Starbucks” turnaround, and macro data that can swing consumer-facing names. SBUX closed Friday, Dec. 12 at $85.35, up modestly from last Friday’s $85.12, after falling as low as $82.28 on Tuesday before recovering across the rest of the week. Starbucks
13 December 2025
····
CME Group Inc. Stock (NASDAQ: CME) This Week: Shares Rebound on Strong Volume Data, SEC Clearing-House Greenlight — Week Ahead Outlook (Updated Dec. 12, 2025)

CME Group Inc. Stock (NASDAQ: CME) This Week: Shares Rebound on Strong Volume Data, SEC Clearing-House Greenlight — Week Ahead Outlook (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025Company: CME Group Inc. (NASDAQ: CME) CME Group stock ended the week on a steadier footing after a midweek dip, closing at $273.55 on Friday, Dec. 12 (up 0.42% on the day). Finviz That finish capped a modest weekly gain driven by a familiar theme for exchange operators: volatility, volumes, and policy-driven market plumbing changes. This week’s CME story wasn’t about a single earnings headline. Instead, investors digested a fresh surge in trading activity (including record crypto participation), regulatory momentum around U.S. Treasury market clearing, and a macro backdrop that continues to feed demand for hedging
13 December 2025
····
Vertex Pharmaceuticals (VRTX) Stock: This Week’s News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Vertex Pharmaceuticals (VRTX) Stock: This Week’s News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Updated: Dec. 12, 2025 (U.S. market close) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) finished Friday at $452.04, extending a late-week rebound after a choppy start to the week. The stock’s intraday range on Friday stretched from $442.94 to $455.99 on volume of about 1.62 million shares, as biotech investors weighed fresh pipeline headlines, Wall Street price-target moves, and a shifting macro backdrop following the Federal Reserve’s latest rate decision. MarketWatch+1 Below is a detailed, publication-ready breakdown of all notable VRTX news from the past several days, the latest analyst forecasts, and what could matter most for next week’s trading. VRTX stock
13 December 2025
·····
Parker-Hannifin (PH) Stock: Deal-Financing Update, This Week’s New Highs, and the Week Ahead (Updated Dec. 12, 2025)

Parker-Hannifin (PH) Stock: Deal-Financing Update, This Week’s New Highs, and the Week Ahead (Updated Dec. 12, 2025)

Updated: December 12, 2025 (U.S. market close) Parker-Hannifin Corporation (NYSE: PH) wrapped up a volatile week still sitting near fresh highs after a rapid run-up earlier in the week. Shares closed Friday at $884.87, down 1.59% on the day, after setting a new 52-week high of $901.31 on Dec. 11. Trading volume on Dec. 12 came in below the stock’s 50-day average, suggesting a bout of profit-taking rather than a broad rush for the exits. MarketWatch The main “bigger picture” narrative behind Parker-Hannifin stock remains unchanged: strong operating momentum (especially in aerospace), a raised fiscal-year outlook, and a major portfolio
13 December 2025
····
1 … 513 514 515 516 517 … 749

Stock Market Today

Carvana stock jumps 5% to $403.67 — here’s what CVNA traders are watching next

Carvana stock jumps 5% to $403.67 — here’s what CVNA traders are watching next

7 February 2026
Carvana shares rose 5.21% Friday to $403.67, rebounding after recent volatility sparked by a short-seller report from Gotham City Research. The company denied allegations of overstated earnings and undisclosed ties to DriveTime. Carvana will report Q4 and full-year 2025 results after markets close on Feb. 18. The January U.S. CPI report is scheduled for Feb. 13.
Confluent stock hugs IBM’s $31 bid — here’s what investors watch next week

Confluent stock hugs IBM’s $31 bid — here’s what investors watch next week

7 February 2026
Confluent shares closed at $30.57 Friday, 43 cents below IBM’s $31-per-share cash offer, ahead of key events next week. The company will report earnings Feb. 11 without a call or outlook, and shareholders vote on the merger Feb. 12. Confluent disclosed 17 demand letters and two lawsuits over proxy disclosures but denies wrongdoing. The IBM deal values Confluent at $11 billion.
Go toTop